Ryan D. Maynard - 23 Feb 2026 Form 3 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Financial Officer
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Ryan D. Maynard
Issuer symbol
FHTX
Transactions as of
23 Feb 2026
Net transactions value
$0
Form type
3
Filing time
24 Feb 2026, 16:01:09 UTC
Previous filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Maynard Ryan D Chief Financial Officer 99 COOLIDGE AVENUE, SUITE 500, WATERTOWN /s/ Michael LaCascia, Attorney-in-Fact for Ryan D. Maynard 24 Feb 2026 0001363984

No securities are beneficially owned.